Can neoadjuvant chemotherapy change clinic pathological and survival parameters in HER-2 positive breast cancer patients?

被引：0
|
作者：
Mundim, F. [1 ]
Franco, A. [1 ]
Infante, K. [1 ]
Neto, J. [1 ]
Brentani, M. M. [1 ]
Facina, G. [1 ]
Waitzberg, A. [1 ]
机构：
[1] Univas Brazil, Pathol, Pouso Alegre, Brazil
来源：
VIRCHOWS ARCHIV | 2018年 / 473卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-02-04
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [1] Pathological Response and Survival after Neoadjuvant Therapy for Her-2 Positive Breast Cancer
    Jinga, Dan Corneliu
    Jinga, Maria Ruxandra
    Miron, Adrian
    Noditi, Aniela
    Blidaru, Alexandru
    CHIRURGIA, 2021, 116 (02) : S91 - S97
  • [2] Pathological complete response in early stage HER-2 positive breast cancer patients, receiving neoadjuvant chemotherapy/Trastuzumab, in a single breast unit in Johannesburg
    Bellomo, A.
    Benn, C.
    Smit, T.
    Heyman, L.
    Rapoport, B.
    BREAST, 2021, 56 : S53 - S54
  • [3] Investigation of the Effect of Low-positive HER-2 on Neoadjuvant Chemotherapy Response in Hormone-positive Breast Cancer Patients
    Karaboyun, Kubilay
    Oznur, Meltem
    Yolcu, Ahmet
    Iriagac, Yakup
    Seber, Selcuk
    JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM, 2023, 13 (01): : 36 - 40
  • [4] Pathological complete response to neoadjuvant chemotherapy and outcomes in Her-2 negative locally advanced breast cancer
    Patel, A. B.
    Sharma, M.
    Joga, S.
    Goel, S.
    Doval, D. C.
    Talwar, V.
    Goyal, S.
    Batra, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S1481 - S1482
  • [5] Prognostic implications of HER2 change after neoadjuvant chemotherapy in HER2-positive breast cancer patients
    Sato, A.
    Maeda, Y.
    Matsumoto, A.
    Ikeda, T.
    Jinno, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1409 - S1409
  • [6] Predictors of lymphovascular invasion in estrogen receptor positive/Her-2 negative breast cancer patients treated with neoadjuvant chemotherapy
    Cavdar, Eyyup
    Iriagac, Yakup
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 1111 - 1117
  • [7] Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy
    Heidy Cedeño
    Rafael Araúz
    Fernando Cebamanos
    Idalmis de Torraza
    Ana Porcell
    BMC Cancer, 7 (Suppl 1)
  • [8] Evaluation of clinical and pathological responses of HER-2 positive locally advanced breast cancer patients after neoadjuvant therapy and surgery
    Bayram, Ertugrul
    Mete, Burak
    Kahramanoglu, Pakize Irem
    Melekoglu, Ebru
    Turker, Mehmet
    Kara, Oguz
    CUKUROVA MEDICAL JOURNAL, 2023, 48 (03): : 1062 - 1071
  • [9] Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer
    Li, Si
    Wei, Wei
    Jiang, Yi
    Li, Qiuyun
    Huang, Qinghua
    Yang, Huawei
    Liu, Jianlun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3085 - 3093
  • [10] Her-2 predicts survival of breast cancer patients
    不详
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1160 - 1160
12345